Beta Bionics, Inc. - BBNX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 23, 2026 | SCHEDULE 13G | Point72 Asset Management, L.P. | 5.2% | 2,290,023 | View |
| Feb 23, 2026 | SCHEDULE 13G | Point72 Capital Advisors, Inc. | 5.2% | 2,290,023 | View |
| Feb 23, 2026 | SCHEDULE 13G | Steven A. Cohen | 5.2% | 2,290,023 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 5.7% | 2,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Roderick Wong | 5.7% | 2,500,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus BB SPV, LLC | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Private Equity Fund I, L.P. | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Private Equity GP I, LLC | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus PE GP I, LLC | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Private Equity Fund II, L.P. | 3.9% | 1,703,961 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Private Equity GP II, LLC | 3.9% | 1,703,961 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus PE GP II, LLC | 3.9% | 1,703,961 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 1.8% | 799,817 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital, LLC | 1.8% | 799,817 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 1.8% | 799,817 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 5.7% | 2,503,778 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus GP, LLC | 5.7% | 2,503,778 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Guy Levy | 5.8% | 2,534,565 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 0.0% | 0 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 0.0% | 0 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 0.0% | 0 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Hadley Harbor Aggregator IV, L.P. | 0.0% | 0 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Zone Healthcare Holdings, LLC | 7.4% | 3,277,220 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Partners, L.P. | 0.5% | 198,706 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners, L.P. | 0.5% | 212,605 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners II, L.P. | 0.2% | 73,147 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners III, L.P. | 0.1% | 49,965 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Four Crossings Institutional Partners V, L.P. | 0.1% | 49,357 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Offshore Investors II, L.P. | 1.0% | 446,621 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital (AM) Investors, L.P. | 0.1% | 29,738 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital F5 Master I, L.P. | 0.1% | 42,561 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Management, L.L.C. | 7.4% | 3,277,220 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Partners, L.L.C. | 2.4% | 1,060,139 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon F5 (GP), L.L.C. | 0.1% | 42,561 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Institutional (GP) V, L.L.C. | 0.1% | 49,357 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Dapice Joshua J. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Dreyfuss, Philip D. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Dunn Hannah E. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Fried, Richard B | 0.0% | 0 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Gehani, Varun N. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Giauque, Nicolas | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Husen, Avner A. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Kim, David T. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Linn, Michael G. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Luo Patrick (Cheng) | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Patel, Rajiv A. | 0.0% | 0 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Roberts, Jr., Thomas G. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Saito Edric C. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Seybold, William | 0.0% | 0 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Short Daniel S. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Spokes, Andrew J. M. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Warren, John R. | 9.9% | 4,379,920 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Wehrly, Mark C. | 9.9% | 4,379,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Zone Healthcare Holdings, LLC | 7.5% | 3,277,220 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Capital Partners, L.P. | 0.4% | 185,460 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Capital Institutional Partners, L.P. | 0.5% | 199,940 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Capital Institutional Partners II, L.P. | 0.2% | 70,718 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Capital Institutional Partners III, L.P. | 0.1% | 47,800 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Four Crossings Institutional Partners V, L.P. | 0.1% | 46,974 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Capital Offshore Investors II, L.P. | 1.0% | 418,307 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Capital (AM) Investors, L.P. | 0.1% | 28,860 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Capital F5 Master I, L.P. | 0.1% | 38,641 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Capital Management, L.L.C. | 7.5% | 3,277,220 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Partners, L.L.C. | 2.3% | 998,059 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon F5 (GP), L.L.C. | 0.1% | 38,641 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Farallon Institutional (GP) V, L.L.C. | 0.1% | 46,974 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Dapice Joshua J. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Dreyfuss, Philip D. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Dunn Hannah E. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Fried, Richard B | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Gehani, Varun N. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Giauque, Nicolas | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Kim, David T. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Linn, Michael G. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Luo Patrick (Cheng) | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Patel, Rajiv A. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Roberts, Jr., Thomas G. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Saito Edric C. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Seybold, William | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Short Daniel S. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Spokes, Andrew J. M. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Warren, John R. | 9.9% | 4,313,920 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Wehrly, Mark C. | 9.9% | 4,313,920 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Morgan Stanley | 8.6% | 3,739,567 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Morgan Stanley Capital Services LLC | 7.8% | 3,384,256 | View |
| Oct 30, 2025 | SCHEDULE 13G | The Vanguard Group | 5.09% | 2,216,185 | View |
| Oct 17, 2025 | SCHEDULE 13G | BlackRock, Inc. | 6.4% | 2,778,764 | View |
| Oct 16, 2025 | SCHEDULE 13G/A | Millennium Management LLC | 1.8% | 796,964 | View |
| Oct 16, 2025 | SCHEDULE 13G/A | Millennium Group Management LLC | 1.8% | 796,964 | View |
| Oct 16, 2025 | SCHEDULE 13G/A | Israel A. Englander | 1.8% | 796,964 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.